Dr. Luc Otten joined Promethera in 2020 as Chief Scientific Officer and works closely with all members of our management team. He supports R&D and product development by leading the integration and transfer of scientific innovation into our business value chains.
Luc also uses his wide-ranging talents to support IP and business development activities, internal and external scientific messaging and corporate governance matters relating to scientific affairs and strategic management.
Before joining Promethera, Luc gained a wealth of financial experience in the health care sector and consulting biotech companies. Furthermore, he is skilled in fundraising, team recruitment and management of academic research groups.
Luc has a medical degree from the University of Geneva, a PhD in immunogenetics and a management degree in life sciences. He has an established track record in medical and biology research with 22 peer-reviewed publications. Luc’s broad network of peers across different life science sectors is invaluable for Promethera.